Project Description
Dr. Reynolds studied the mechanisms of action of N-(4-hydroxyphenyl) retinamide (4-HPR) as an inhibitor of the growth of various neuroblastoma cell lines in order to define the types of patients likely to benefit from use of 4-HPR.